Hirtle Callaghan & Co’s Medtronic MDT Stock Holding History

Hirtle Callaghan & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,449	Closed	-$405K	–	108
2018 Q4	$405K	Hold	4,449	–	–	0.04%	66
2018 Q3	$438K	Hold	4,449	–	–	0.04%	65
2018 Q2	$381K	Sell	4,449 -3,496	-44%	-$292K	0.04%	72
2018 Q1	$637K	Hold	7,945	–	–	0.06%	51
2017 Q4	$642K	Sell	7,945 -404	-5%	-$32.4K	0.06%	48
2017 Q3	$649K	Buy	8,349 +5,449	+188%	+$452K	0.06%	48
2017 Q2	$258K	Buy	2,900 +2,396	+475%	+$202K	0.04%	17
2017 Q1	$40K	Hold	504	–	–	0.01%	91
2016 Q4	$36K	Sell	504 -5,791	-92%	-$455K	0.01%	83
2016 Q3	$544K	Hold	6,295	–	–	0.11%	50
2016 Q2	$546K	Sell	6,295 -360	-5%	-$29.1K	0.1%	50
2016 Q1	$500K	Buy	6,655 +1,962	+42%	+$148K	0.09%	51
2015 Q4	$360K	Sell	4,693 -2,430	-34%	-$183K	0.08%	22
2015 Q3	$476K	Hold	7,123	–	–	0.08%	24
2015 Q2	$528K	Buy	+7,123	New	+$544K	0.18%	20
2015 Q1	–	Sell	-7,373	Closed	-$534K	–	232
2014 Q4	$534K	Sell	7,373 -22	-0.3%	-$1.53K	0.12%	106
2014 Q3	$458K	Sell	7,395 -5	-0.1%	-$318	0.08%	118
2014 Q2	$472K	Hold	7,400	–	–	0.07%	144
2014 Q1	$455K	Hold	7,400	–	–	0.08%	137
2013 Q4	$427K	Buy	7,400 +1,565	+27%	+$88.7K	0.06%	144
2013 Q3	$311K	Buy	+5,835	New	+$314K	0.05%	179

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hirtle Callaghan & Co's MDT Position: Q1 2019 in Review

Hirtle Callaghan & Co sold out of Medtronic (MDT) in Q1 2019, closing a stake of 4,449 shares — an estimated $405K sold.

Hirtle Callaghan & Co first reported a position in MDT in Q3 2013 and held it in 21 quarters. The position peaked at $649K in Q3 2017. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

Hirtle Callaghan & Co reported no remaining Medtronic position as of Q1 2019 after selling out during the quarter.
Hirtle Callaghan & Co sold 4,449 Medtronic shares in Q1 2019, an estimated $405K.
Hirtle Callaghan & Co first reported a position in Medtronic in Q3 2013 and held it in 21 quarters.
Hirtle Callaghan & Co's Medtronic position peaked at $649K in Q3 2017.
1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2019, filed 14 May 2019.